Skip to content
Search

Latest Stories

UK to start plasma trials  to treat Covid-19 patients

Britain is to start trials to see whether plasma collected from donors who have recovered from Covid-19 could be an effective treatment for patients who are severely unwell with the disease.

Up to 5,000 severely ill patients with Covid-19 could soon be treated each week with plasma as part of a new approach to treating the virus, the health department said on Saturday.


Plasma from recovered Covid-19 patients can be transfused to patients who are struggling to produce their own antibodies against the virus.

So-called convalescent plasma was used as an effective treatment during the 2002 to 2004 SARS outbreak, the health department said.

In parallel with the national randomised clinical trial, the government is scaling up the national programme for collecting plasma so the treatment can be widely rolled out if it is shown to be effective, the department said.

The collection of plasma would be ramped up over April and May to deliver up to 10,000 units of plasma to the National Health Service (NHS) every week, enough to treat 5,000 Covid-19 patients per week.

"I have every hope this treatment will be a major milestone in our fight against this disease," said health minister Matt Hancock.

Professor Jonathan Van-Tam, Deputy Chief Medical Officer said: “The UK is leading the world’s largest trials to find a treatment for Covid-19, with over 7,000 people so far involved testing a range of medicines; we hope to add convalescent plasma to this list shortly."

He added: “Convalescent plasma has been used as an effective treatment for emerging infections in the past, and this step forward underpins our science-backed approach to fighting this virus.”

The NHS will contact people in England who have recovered from Covid-19 and could be possible donors.

Blood is taken from one arm and circulated through a machine that separates out the plasma, and then returned to the donor. The process takes about 45 minutes and provides two units of plasma per donation, which can also be frozen and stored ahead for any future need.

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less